Consensus IDEXX Laboratories, Inc.

Equities

IDXX

US45168D1046

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
539.9 USD +0.07% Intraday chart for IDEXX Laboratories, Inc. +1.47% -2.72%

Evolution of the average Target Price on IDEXX Laboratories, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e06bd1ba65d1cc0c6fded9141.GOLzOzfEVuY2nsnXDm0L_TpHThN_xmYXpOSXJTVRoW8.U5GGU02nHKlnyJGnaw56i3YwGWdH9ARE1bT5EEIA0hlVrcZSB7Qh33n6_Q~2fde2d5daab73ab6fedaeb1e990663b3
ANALYST RECOMMENDATIONS : Coinbase, Fortinet, Nike, Chipotle, Nvidia... Our Logo
JPMorgan Adjusts Price Target on IDEXX Laboratories to $630 From $600, Maintains Overweight Rating MT
Morgan Stanley Lifts PT on IDEXX Laboratories to $620 From $600 After 'Impressive' Q4 2023 Upside, 'Solid' 2024 Guide; Overweight Kept MT
Barclays Adjusts Price Target on IDEXX Laboratories to $655 From $605, Keeps Overweight Rating MT
Stifel Adjusts Price Target on IDEXX Laboratories to $570 From $525, Keeps Hold Rating MT
Piper Sandler Downgrades IDEXX Laboratories to Neutral From Overweight, Price Target is $525 MT
ANALYST RECOMMENDATIONS : Adobe, AMD, Astrazeneca, Home Depot, Netflix... Our Logo
Goldman Sachs Hikes Price Target on IDEXX Laboratories to $650 From $500, Maintains Buy Rating MT
ANALYST RECOMMENDATIONS : AMD, Cloudflare, Intel, ITV, PayPal... Our Logo
Are rate cuts are coming early next year? Our Logo
ANALYST RECOMMENDATIONS : Biogen, Boeing, Chevron, Rio Tinto, Salesforce... Our Logo
ANALYST RECOMMENDATIONS : Best Buy, Glencore, Lowe's, Nvidia, Clorox... Our Logo
Piper Sandler Increases Price Target on IDEXX Laboratories to $525 From $520, Maintains Overweight Rating MT
ANALYST RECOMMENDATIONS : Amazon, Exxon Mobil, Ford, Walt Disney, PayPal... Our Logo
Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $500 From $578, Maintains Buy Rating MT
Stifel Cuts IDEXX Laboratories' Price Target to $460 From $500, Maintains Hold Rating MT
ANALYST RECOMMENDATIONS : Abrdn, Best Buy, Dollar General, Lowe's, Target... Our Logo
Stifel Adjusts Price Target on IDEXX Laboratories to $500 From $525, Keeps Hold Rating MT
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $600 From $590, Maintains Overweight Rating MT
Atlantic Equities Downgrades IDEXX Laboratories to Neutral From Overweight, Price Target is $600 MT
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $590 From $543, Maintains Overweight Rating MT
Barclays Raises IDEXX Laboratories' Price Target to $590 From $582, Maintains Overweight Rating MT
JPMorgan Adjusts IDEXX Laboratories' Price Target to $550 From $525, Keeps Overweight Rating MT
Atlantic Equities Raises Price Target on IDEXX Laboratories to $600 From $470, Maintains Overweight Rating MT
Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $530 From $465, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
539.9 USD
Average target price
585.8 USD
Spread / Average Target
+8.50%
High Price Target
675 USD
Spread / Highest target
+25.02%
Low Price Target
400 USD
Spread / Lowest Target
-25.92%

Consensus detail

Consensus revision (last 18 months)

Analysts covering IDEXX Laboratories, Inc.

JPMorgan Chase
Stifel Nicolaus
Barclays
Morgan Stanley
Piper Sandler
Goldman Sachs
Atlantic Equities
BofA Securities
Credit Suisse
Guggenheim
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings